Rasburicase

Rasburicase prevents rise in uric acid levels specifically in cancer patients undergoing chemotherapy. The drug is prescribed to patients who have leukemia and cancer of the lymph nodes. It is known to be a urate dase enzyme.

During the process of chemotherapy, cancer cells are attacked and killed. When this occurs, very large quantities of uric acid is produced in the body, which can result in complications. Thus, Rasburicase maintains normal uric acid levels, by helping the kidney discard the excess.

The drug is administered with the help of an injection. It should not be shaken before use. Avoid using Rasburicase if the bottle is cloudy or cracked.

Common side effects that can occur after using Rasburicase are headache, constipation, diarrhea, nausea, ulcers in the mouth, pain in the stomach and vomiting. Beware of any major allergic reactions to the drug. Inform your doctor if you experience any symptoms like itching, hives, redness of the skin, problems with breathing, chills, pain in the chest or dizziness.

Uric acid tests are commonly performed in patients taking this drug. Certain other tests will also be prescribed from time to time.

The drug should be used only if necessary in case of children who are less than 2 years of age.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

• Nausea

• Headache

• Vomiting

• Rash

• Urticaria

• Fever

• Diarrhoea

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

• Is It safe with alcohol?

  Interaction with alcohol is unknown. Please consult your doctor.

• Are there any pregnancy warnings?

  Rasburnat 1.5mg injection may be unsafe to use during pregnancy.
  Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.

• Are there any breast-feeding warnings?

  Unknown. Human and animal studies are not available. Please consult your doctor.

• Is it safe to drive while on this medicine?

  There is no data available. Please consult doctor before consuming the drug.

• Does this affect kidney function?

  There is no interaction between renal impairment and consuming this drug. So dose alteration is not needed.

• Does this affect liver function?

  There is no data available. Please consult doctor before consuming the drug.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

Below is the list of medicines, which contains Rasburicase as ingredient

• Rasburnat 1.5Mg Injection

  Natco Pharma Ltd

• Rasbelon 1.5mg Injection

  Celon Laboratories Ltd

• Rasby 1.5mg Injection

  Intas Pharmaceuticals Ltd

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

This medication is used to control acute myelogenous leukaemia, non-Hodgkin''s lymphoma and lymphoid leukaemia. An inactive and soluble metabolite is formed after the drug catalyzes enzymatic oxidation of uric acid.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

• Rasburicase-Drug Information Portal [Internet].druginfo.nlm.nih.gov 2022 [Cited 17 June 2022].Available from:

  https://druginfo.nlm.nih.gov/drugportal/name/rasburicase

• Rasburicase-DrugBank Online [Internet].go.drugbank.com 2022 [Cited 17 June 2022].Available from:

  https://go.drugbank.com/drugs/DB00049